Indians, Racial Attacks & Philanthropy in the U.S.


How Indian Immigrants in the U.S. can Counter Racist Attacks

Opinion Piece by Ignatius Chithelen published by India O April 2017

Between January and April 2017, there were at least three physical attacks on Indian immigrants in the US, resulting in two deaths. One of the those killed was 32 year old engineer  Srinivas Kuchibhotla, in photo below, with his wife :



It is in the self-interest of Indian billionaires and chief executives in the U.S. to become major philanthropists, funding human rights, civil liberties, social and political groups, to counter racist attacks, says Ignatius Chithelen in this opinion piece published by India Today Online.

"Several Indian immigrants have achieved major financial success as founders and investors, mostly in technology companies and as chief executives of major US corporations.
"Only Kiran Mazumdar-Shaw and six other Indian billionaires, in India and the US, have signed the Giving Pledge initiated by American billionaires Warren Buffett and Bill Gates. The pledge is a public commitment by the world’s billionaires and their families to give most of their wealth to philanthropy.
"Traditionally, Indian billionaires, like many from other countries, donate small amounts seeking business and political returns and for social climbing. Funding programs to improve the lives of the less fortunate are not popular due to the belief that the poor are lazy and do not seek work."





Comments

Post a Comment

Popular posts from this blog

Satish Mehta CEO of Emcure Pharmaceuticals and a Drug Price-Fixing Scandal

The Billionaire And The Drug Price-Fixing Scandal. Forbes article Satish Mehta founded Emcure Pharmaceuticals in 1981. In 2011 Emcure bought U.S. based Heritage Pharmaceuticals founded by Jeffrey Glazer. In 2016 Heritage had U.S. sales of $265 million, 40% of Emcure's total sales. An article in Forbes , by Nathan Vardi and Nazneen Karmali April 25, 2017, says that, " In September 2015, Satish Mehta, the billionaire chief executive of the Indian drug company Emcure Pharmaceuticals, wrote an effusive email congratulating Jeffrey Glazer, the CEO of his U.S. crown jewel, Heritage Pharmaceuticals, on a job well done. "In a short span of 4.5 years, you have taken Heritage to another level," Mehta wrote, adding that he considered Glazer to be "an integral part of our family." In January this year, the article continues, "Glazer pleaded guilty to violating U.S. antitrust law by conspiring with manufacturers to fix the prices of generic drugs. Glazer is
Read more

Why Second Generation Indians in U.S. will not be as Successful:

Image
The Bamboo Ceiling for Asians at U.S. Colleges Extract from "Six Degrees of Education: From Teaching in Mumbai to Investment Research in New York" by Ignatius Chithelen  Published by India Today Online August 3, 2016  Why Second Generation Indians in the U.S. will not be as Successful S ince the 1980s, several million Indians have studied at U.S. colleges. Over a million have stayed on in the U.S. through employment visas and many of them have become successful as professionals and some as entrepreneurs. They include chief executives of major U.S. companies such as Sundar Pichai at Google, Satya Nadella at Microsoft, Shantanu Narayen at software vendor Adobe, Indra Nooyi at Pepsico and Rakesh Sachdev of chemicals and bio-chemicals supplier Sigma-Aldrich. Businesses founded or co-founded by Indians in the U.S. include Cascade Communications, Daisy Systems, Epitome, Hotmail, Junglee, Morphotek, Solar Junction and TIBCO Software.  Some Indian en
Read more